Mark Zaleski, Associated Press file
Some epinephrine auto-injector manufacturers haven’t complied with a requirement that they reimburse Colorado pharmacies for pens sold to residents under the state’s $60 price cap. 
Getting your player ready...
Over the last three years, Colorado set limits on out-of-pocket costs for insulin and epinephrine auto-injectors. So far, insulin makers largely complied with the laws, but that hasn't been the case with some of those who make EpiPens and generic auto-injectors.
Already have an account Log In
This article is only available to subscribers
Trusted Local News
Standard Digital
$1 for 1 year
Offer valid for non-subscribers only
